Skip to main content
. Author manuscript; available in PMC: 2014 Sep 4.
Published in final edited form as: Ther Deliv. 2013 Apr;4(4):453–462. doi: 10.4155/tde.13.16

Figure 6.

Figure 6

Exploiting endogenous IgG binding for targeted delivery. An antibody (Herceptin) that is known to bind the Her-2 receptor was adsorbed to lipoplexes (20% DOTAP/80% cholesterol), and used to transfect Her-18 cells that overexpress this receptor. No enhancement of transfection was observed. Each bar represents the mean transfection of 5 individual wells, and the error bars represent the standard errors.